Tag: Haleon
Haleon’s Proton Pump Inhibitors (PPIs) witnessed 13% growth in pharmacy recommendations
Despite a 13 per cent increase from last year, less than a quarter (21%) of pharmacy teams recommend Proton Pump Inhibitors (PPIs) as a...
New GSK raises 2022 forecast for second time in four months
New GSK raised its 2022 forecast for the second time this year, after third-quarter earnings and sales topped estimates, continuing its strong start as...
EXCLUSIVE: Raising the bar for patient care
Global consumer healthcare company Haleon has launched a new center of excellence for a global leader in consumer health which will bring together world...
Drugmakers’ shares stabilise after Zantac litigation slump
Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday (Aug 12) after the companies said that nothing material had changed regarding...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns; J&J ends talcum powder sale
Shares in GSK, Sanofi and Haleon fell sharply on Thursday (August 11) amid growing investor concerns about US litigation focused on a heartburn drug...
New Panadol campaign celebrates the moment when release from pain begins
Panadol launched a new purpose-led brand idea as part of a multi-channel campaign across Great Britain and Ireland. With nine out of 10 people...